NCT02601950 2025-06-22A Study of Tazemetostat in Adult Participants With Soft Tissue SarcomaIpsenPhase 2 Completed267 enrolled 25 charts 2 FDA
NCT02815995 2025-06-12Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma SubtypesM.D. Anderson Cancer CenterPhase 2 Completed57 enrolled 18 charts